A California federal judge has determined that biotech company Biogen owes Roche's Genentech more than $88 million in patent royalties for sales of Biogen's blockbuster multiple-sclerosis and Crohn's ...
Affiliated with the UB Institute for Artificial Intelligence and Data Science, the lab allows Ramanathan and his interdisciplinary team to apply AI, deep learning, large language models, ...
Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (Upstream: QNTM) (“Quantum BioPharma” or the “Company”), a biopharmaceutical company dedicated to building a ...
The National Association of Specialty Pharmacy (NASP) recognizes the urgent need to address prescription drug affordability and applauds the Administration’s efforts to reduce costs for patients. The ...
Minister for Education Aseri Radrodro outside Parliament on October 1, 2025. Photo: Parliament of Fiji Drug testing in schools requires parental consent and is currently a work in progress before ...
French biotech EG 427 has had success with its urinary incontinence DNA therapy, EG110A, showing a more than 80% reduction in episodes. In the Phase Ib/IIa trial (NCT06596291), the lowest dose of ...
Ms Street said: "Every time I bought another pouch of tobacco, I'd cringe and think that's half a week's worth of shopping. It's scary how much we were spending." The council urged people to give up ...
TORONTO, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (Upstream: QNTM) (“Quantum BioPharma” or the “Company”), a biopharmaceutical company dedicated ...
Treatment with Sanofi's frexalimab was seen in a study to safely maintain disease control over 2.5 years in adults with relapsing forms of MS.
A mother who was given 12 months to live in 2015 is readying for a liver transplant and says it's a "miracle" she is still alive. Heidi Loughlin, from Portishead in North Somerset, was diagnosed with ...
Rhapsido is the first and only Bruton’s tyrosine kinase (BTK) inhibitor approved for chronic spontaneous urticaria (CSU). The FDA has approved Rhapsido (remibrutinib), an oral treatment for adult ...
The decree, which comes as tensions with the US threaten to boil over, would allow Mr Maduro to mobilise his armed forces.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback